ArticleOncotarget2017
Characteristics and genetic diversity of multi-drug resistant extended-spectrum beta-lactamase (ESBL)-producing
Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it.
- The Prevalence ofFrontiers in veterinary science · 2022Pooled it
- Bovine mastitis and antimicrobial resistance in Pakistan's dairy sector: current status and future prospects.Veterinary research communications · 2025Review
- Antimicrobial susceptibility profiling of caprine clinical mastitis pathogens in Punjab, India.Annals of medicine and surgery (2012) · 2025Article
- Occurrence of antimicrobial-resistant bovine mastitis bacteria in Sakon Nakhon, Thailand.Veterinary world · 2024Article
- Article
- Extended-Spectrum β-Lactamases (ESBL): Challenges and Opportunities.Biomedicines · 2023Review
- Extended-Spectrum β-Lactamases (ESBL) Producing Bacteria in Animals.Antibiotics (Basel, Switzerland) · 2023Review
- Immunological and Oxidative Biomarkers in Bovine Serum from Healthy, Clinical, and Sub-Clinical Mastitis Caused byAnimals : an open access journal from MDPI · 2023Article
- The Diversity ofMicroorganisms · 2023Review
- Genomic Characterization of an Extensively Drug-Resistant Extra-Intestinal Pathogenic (ExPEC)Antibiotics (Basel, Switzerland) · 2022Article
- Lineages, Virulence Gene Associated and Integrons among Extended Spectrum β-Lactamase (ESBL) and CMY-2 ProducingPathogens (Basel, Switzerland) · 2022Article
- Prevalence and Profiles of Antibiotic Resistance GenesMicroorganisms · 2022Article
- Frequently used therapeutic antimicrobials and their resistance patterns onInternational journal of veterinary science and medicine · 2022Article
- Review
- New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria, Switzerland, 2019-2020.Emerging infectious diseases · 2021Article
- Biogenic Synthesis, Characterization and Antibacterial Potential Evaluation of Copper Oxide Nanoparticles Against Escherichia coli.Nanoscale research letters · 2021Article
- Comparative occurrence and antibiogram of extended-spectrum β-lactamase-producingVeterinary world · 2021Article
- Companion Animals Emerged as an Important Reservoir of Carbapenem-Resistant Enterobacteriaceae: A Report from India.Current microbiology · 2021Article
- Characterization of Enterococci- and ESBL-ProducingPathogens (Basel, Switzerland) · 2021Article
- Epidemiological Characterization of Colistin and Carbapenem Resistant Enterobacteriaceae in a Tertiary: A Hospital from Anhui Province.Infection and drug resistance · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A characterization of the drug resistance profiles, identification of PCR-based replicon typing, and multilocus sequence typing (MLST) and analysis of 46 ESBL-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.